DrugPatentWatch Database Preview
DESVENLAFAXINE Drug Profile
» See Plans and Pricing
Which patents cover Desvenlafaxine, and what generic alternatives are available?
Desvenlafaxine is a drug marketed by Alembic Pharms Ltd, Sun Pharma Global, Teva Pharms Usa, Actavis Labs Fl, Casi Pharms Inc, Hikma, Intellipharmaceutics, Lupin Ltd, Mylan, Yichang Humanwell, and Zydus Pharms. and is included in thirteen NDAs.
The generic ingredient in DESVENLAFAXINE is desvenlafaxine succinate. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desvenlafaxine succinate profile page.
US ANDA Litigation and Generic Entry Outlook for Desvenlafaxine
A generic version of DESVENLAFAXINE was approved as desvenlafaxine succinate by ALEMBIC PHARMS LTD on June 29th, 2015.
Summary for DESVENLAFAXINE
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 13 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 93 |
| Clinical Trials: | 65 |
| Patent Applications: | 1,039 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for DESVENLAFAXINE |
| DailyMed Link: | DESVENLAFAXINE at DailyMed |
US Patents and Regulatory Information for DESVENLAFAXINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic Pharms Ltd | DESVENLAFAXINE | desvenlafaxine | TABLET, EXTENDED RELEASE;ORAL | 204150-001 | Mar 4, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Intellipharmaceutics | DESVENLAFAXINE SUCCINATE | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 204805-001 | May 7, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Yichang Humanwell | DESVENLAFAXINE SUCCINATE | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 210014-001 | Oct 1, 2018 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Actavis Labs Fl | DESVENLAFAXINE SUCCINATE | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 204065-001 | Jul 29, 2016 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Sun Pharma Global | DESVENLAFAXINE | desvenlafaxine fumarate | TABLET, EXTENDED RELEASE;ORAL | 205583-002 | Jan 28, 2014 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Alembic Pharms Ltd | DESVENLAFAXINE SUCCINATE | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 204003-002 | Jun 29, 2015 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Lupin Ltd | DESVENLAFAXINE SUCCINATE | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 204172-001 | Jun 29, 2015 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
